Proactive Investors - Run By Investors For Investors

Preveceutical Medical making headway with cannabinoid delivery system

Health sciences and in particular new ways of thinking about drug delivery and disease prevention have made some significant advances in recent times.

One company on the cutting edge of preventative medicine is Vancouver based PreveCeutical Medical (CSE: PREV) (OTC: PRVCF) which focuses on innovation in the health science space.

The company's research team, led by Harry Parekh out of the R&D laboratory at the University of Queensland, has some exciting developments in drug delivery and pain management.

Preveceutical Medical is currently working on applying its Sol Gel technology to the delivery of cannabinoids to effectively treat  diseases like multiple sclerosis, paediatric epilepsy and chronic pain.

Maher Khaled, the CEO of the company's Australian arm, says the business is also looking for new opportunities as scientific evidence for cannabinoid treatments builds.

"We'll be looking at other areas and diseases where strong evidence comes to support them as we progress" says Mr Khaled.

View full PREV profile View Profile

PreveCeutical Medical Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use